Organogenesis received confirmation to initiate a license application with the Food and Drug Administration for its knee condition treatment ReNu. The regenerative tissue company said Monday it plans ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to ...
Vanda Pharmaceuticals shares rose after the company said it had submitted a biologics license application to the Food and Drug Administration for its generalized pustular psoriasis treatment. The ...
A Bolton fast-food restaurant has applied for a new licence to serve food and drink until the early hours of the morning - even on weekdays.
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) ...
US FDA Grants Priority Review to Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Chemotherapy Combination for Classic Hodgkin Lymphoma ...
Sherman Phoenix launched Taste to Table Food Business Growth Series in partnership with the Wisconsin Economic Development ...
The Bolton News on MSN
Plans submitted for controversial license extension at Bolton takeaway
A Bolton fast-food restaurant has applied for a new licence to serve food and drink until the early hours of the morning - even on weekdays.
Pushback from Sherman Park residents for a proposed restaurant and lounge sways Common Council committee to reject liquor ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...
Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd , has entered into two strategic agreements with privately held Hasten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback